DK169742B1 - Anvendelse af chromanderivater - Google Patents

Anvendelse af chromanderivater Download PDF

Info

Publication number
DK169742B1
DK169742B1 DK344585A DK344585A DK169742B1 DK 169742 B1 DK169742 B1 DK 169742B1 DK 344585 A DK344585 A DK 344585A DK 344585 A DK344585 A DK 344585A DK 169742 B1 DK169742 B1 DK 169742B1
Authority
DK
Denmark
Prior art keywords
compound
cyano
alkyl
trans
represents hydrogen
Prior art date
Application number
DK344585A
Other languages
Danish (da)
English (en)
Other versions
DK344585D0 (da
DK344585A (da
Inventor
John Morris Evans
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK344585D0 publication Critical patent/DK344585D0/da
Publication of DK344585A publication Critical patent/DK344585A/da
Application granted granted Critical
Publication of DK169742B1 publication Critical patent/DK169742B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK344585A 1984-07-31 1985-07-29 Anvendelse af chromanderivater DK169742B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848419515A GB8419515D0 (en) 1984-07-31 1984-07-31 Treatment
GB8419515 1984-07-31

Publications (3)

Publication Number Publication Date
DK344585D0 DK344585D0 (da) 1985-07-29
DK344585A DK344585A (da) 1986-02-01
DK169742B1 true DK169742B1 (da) 1995-02-13

Family

ID=10564723

Family Applications (1)

Application Number Title Priority Date Filing Date
DK344585A DK169742B1 (da) 1984-07-31 1985-07-29 Anvendelse af chromanderivater

Country Status (8)

Country Link
US (1) US4786639A (ja)
EP (1) EP0176689B1 (ja)
JP (1) JPS6143113A (ja)
AU (1) AU579390B2 (ja)
DE (1) DE3585762D1 (ja)
DK (1) DK169742B1 (ja)
GB (1) GB8419515D0 (ja)
ZA (1) ZA855679B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
EP0301713A3 (en) * 1987-07-07 1990-05-02 Beecham Group Plc Chroman derivatives for treatment of pulmonary hypertension
GB8730051D0 (en) * 1987-12-23 1988-02-03 Beecham Group Plc Novel compounds
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
US5254557A (en) * 1988-05-09 1993-10-19 Beecham Group P.L.C. Compound and treatment
EP0373204A1 (en) * 1988-05-09 1990-06-20 Beecham Group Plc Novel compounds and treatment
US5364878A (en) * 1988-07-19 1994-11-15 Hoechst Aktiengesellschaft Use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag, 6230 Frankfurt Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
GB8822743D0 (en) * 1988-09-28 1988-11-02 Beecham Group Plc Novel compounds
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
ES2071668T3 (es) * 1988-12-13 1995-07-01 Beecham Group Plc Benzopirano y compuestos relacionados.
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
DE3922392A1 (de) 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
DE3926001A1 (de) * 1989-08-05 1991-02-07 Merck Patent Gmbh Chromanderivate
US5095016A (en) * 1989-08-11 1992-03-10 Kaken Pharmaceutical Co., Ltd. Benzopyran compounds, processes for their production and pharmaceutical compositions
WO1991009031A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Trifluoromethyl substituted compounds and a pharmaceutical composition
WO1992012973A1 (fr) * 1991-01-23 1992-08-06 Nippon Kayaku Kabushiki Kaisha Derive de chromane
TW244350B (ja) * 1991-12-14 1995-04-01 Hoechst Ag
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
JP4736214B2 (ja) * 2001-03-19 2011-07-27 大日本印刷株式会社 電子レンジ用紙カップ
JP2003026141A (ja) * 2001-07-19 2003-01-29 Dainippon Printing Co Ltd 電子レンジ対応紙カップおよびその製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
DE3364145D1 (de) * 1982-04-08 1986-07-24 Beecham Group Plc Antihypertensive benzopyranols
DE3368629D1 (en) * 1982-04-28 1987-02-05 Beecham Group Plc Novel chromenes and chromans
DE3368057D1 (en) * 1982-05-21 1987-01-15 Beecham Group Plc Pharmaceutically active aminobenzopyrans
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308063D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
EP0126367B1 (en) * 1983-05-18 1994-10-12 Beecham Group Plc Chroman and chromene derivatives

Also Published As

Publication number Publication date
AU579390B2 (en) 1988-11-24
EP0176689A3 (en) 1989-08-02
DE3585762D1 (de) 1992-05-07
JPS6143113A (ja) 1986-03-01
DK344585D0 (da) 1985-07-29
US4786639A (en) 1988-11-22
ZA855679B (en) 1987-03-25
DK344585A (da) 1986-02-01
EP0176689A2 (en) 1986-04-09
EP0176689B1 (en) 1992-04-01
GB8419515D0 (en) 1984-09-05
AU4554785A (en) 1986-02-06

Similar Documents

Publication Publication Date Title
DK169742B1 (da) Anvendelse af chromanderivater
US20210052599A1 (en) Drug therapy for preventing or treating glaucoma
US4772603A (en) Method for treating congestive heart failure, angina, occlusive peripheral vascular disease or cerebral vascular disease in mammals
CA2406947A1 (en) Methods for prevention and treatment of gastrointestinal disorders
KR0139626B1 (ko) 강심제
US4738963A (en) Method for the treatment of incontinence in mammals
US4891380A (en) Novel treatment
US10703745B2 (en) Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
US20190336513A1 (en) Thromboxane receptor antagonists
AU619567B2 (en) Compounds with bronchodilator activity
US5032596A (en) Treatment of disorders associated with pulmonary hypertension and/or right heart failure
EP0744950B1 (en) Agent for prophylaxis and treatment of thromboxane a2 mediated diseases
RU2212237C2 (ru) Средство для лечения нейрогенного воспаления
US5137904A (en) Thiohydantoin inhibitors of collagen-induced and ADP-induced platelet aggregation
RU2229885C2 (ru) Средство для лечения нарушения функции эрекции
US10738042B2 (en) Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
US20190330250A1 (en) Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer
JPS6038377A (ja) 新規ベンゾフラン誘導体、その製造法および該誘導体を含む医薬組成物
CA2357110A1 (en) Method for the treatment of polycystic kidney disease
Chess-Williams et al. Temperature dependence of β1-adrenoceptor-mediated responses examined by use of partial agonists
EP0679649B1 (en) 2,3-Dihydrobenzofuran Derivatives
KR20030002304A (ko) 3-페닐-3,7-디아자비시클로[3.3.1]노난 화합물들과 이들의제조방법 및 이러한 화합물들을 포함하는 약제들
JPH10501263A (ja) 平滑筋弛緩薬としてのシクロブタ−3−エン−1,2−ジオン誘導体
CN117440811A (zh) 用于治疗与核糖体障碍相关的贫血的组合物和方法
Zhang et al. Nicardipine suppresses bronchoconstrictor actions of pharmacologic agents in guinea pigs

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired